Hepatitis B Virus Reactivation After Cytotoxic Chemotherapy: The Disease and Its Prevention
β Scribed by Mindikoglu, Ayse L.; Regev, Arie; Schiff, Eugene R.
- Book ID
- 121772927
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 122 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1542-3565
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Hepatitis B virus (HBV) reactivation has been described in cancer patients who received cytotoxic/immunosuppressive therapy and may result in liver damage of varying degrees of severity. There is no known effective treatment. Lamivudine, a nucleoside analogue, has been found to suppress HBV replicat
## Abstract The diagnosis of HBV reactivation during cytotoxic chemotherapy is based on an abrupt rise in levels of serum HBV DNA in conjunction with a hepatitic picture and in the absence of other causes of hepatitis. However, several cases of βhepatitisβ have been noted during chemotherapy in HBs